[en] Liver transplantation (LT) remains the only curative option for patients suffering from end-stage liver disease, acute liver failure and selected hepatocellular carcinomas and access to the LT-waiting list is limited to certain strict indications. However, LT has shown survival advantages for patients in certain indications such as acute alcoholic hepatitis, hepatocellular carcinoma outside Milan criteria and colorectal cancer metastases. These newer indications increase the pressure in an already difficult context of organ shortage. Strategies to increase the transplantable organ pool are therefore needed. We will discuss here the use of HCV positive grafts as the use of normothermic isolated liver perfusion. Belgian Liver Intestine Advisory Committee (BeLIAC) from the Belgian Transplant Society (BTS) aims to guarantee the balance between the new indications and the available resources.
Disciplines :
Gastroenterology & hepatology Surgery
Author, co-author :
Dahlqvist, G.
Moreno, C.
Starkel, P.
Detry, Olivier ; Université de Liège - ULiège > Département des sciences cliniques > Pathologie chirurgicale abdominale et endocrinienne
Coubeau, L.
Jochmans, I.
Language :
English
Title :
Innovations in liver transplantation in 2020, position of the Belgian Liver Intestine Advisory Committee (BeLIAC).
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Mathurin, P., Moreno, C., Samuel, D., Dumortier, J., Salleron, J., Durand, F., Early liver transplantation for severe alcoholic hepatitis (2011) N. Engl. J. Med., 365, pp. 1790-1800
Sapisochin, G., Hibi, T., Ghobrial, M., Man, K., The ILTS Consensus Conference on Transplant Oncology: Setting the Stage (2020) Transplantation, 104
Duvoux, C., Roudot-Thoraval, F., Decaens, T., Pessione, F., Badran, H., Piardi, T., Liver transplantation for hepatocellular carcinoma: A model including α-fetoprotein improves the performance of Milan criteria (2012) Gastroenterology, 143, pp. 986-994. , e983
quiz e914-985
Schielke, A., Meurisse, N., Lamproye, A., Honoré, P., Delwaide, J., Hustinx, R., Selection criteria for liver transplantation in patients with hepatocellular carcinoma. Eastern and western experiences, and perspectives for the future (2019) Acta Gastroenterol. Belg., 82, pp. 314-318
Majno, P., Mentha, G., Giostra, E., Terraz, S., Rubbia-Brandt, L., Berney, T., Treatment of hepatocellular carcinoma at the dawn of the third millennium: Liver transplantation and its alternatives (2004) Acta Gastroenterol. Belg., 67, pp. 206-222
Hagness, M., Foss, A., Line, P.D., Scholz, T., Jorgensen, P.F., Fosby, B., Liver Transplantation for Nonresectable Liver Metastases From Colorectal Cancer (2013) Annals of Surgery, 257, pp. 800-806
Hibi, T., Rela, M., Eason, J.D., Line, P.-D., Fung, J., Sakamoto, S., (2020) Liver Transplantation for Colorectal and Neuroendocrine Liver Metastases and Hepatoblastoma, p. 104. , Working Group Report From the ILTS Transplant Oncology Consensus Conference, Transplantation
Deruytter, E., van Steenkiste, C., Trépo, E., Geerts, A., van Vlierberghe, H., Berrevoet, F., Liver transplantation for alcoholic liver disease: A retrospective analysis of recidivism, survival and risk factors predisposing to alcohol relapse (2013) Acta Gastroenterol. Belg., 76, pp. 282-290
Dom, G., Francque, S., Michielsen, P., Risk for relapse of alcohol use after liver transplantation for alcoholic liver disease: A review and proposal of a set of risk assessment criteria (2010) Acta Gastroenterol. Belg., 73, pp. 247-251
EASL Clinical Practice Guidelines: Management of alcohol-related liver disease (2018) J. Hepatol., 69, pp. 154-181
Crabb, D.W., Bataller, R., Chalasani, N.P., Kamath, P.S., Lucey, M., Mathurin, P., Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia (2016) Gastroenterology, 150, pp. 785-790
Louvet, A., Thursz, M.R., Kim, D.J., Labreuche, J., Atkinson, S.R., Sidhu, S.S., Corticosteroids Reduce Risk of Death Within 28 Days for Patients With Severe Alcoholic Hepatitis, Compared With Pentoxifylline or Placebo-a Meta-analysis of Individual Data From Controlled Trials (2018) Gastroenterology, 155, pp. 458-468. , e458
Louvet, A., Naveau, S., Abdelnour, M., Ramond, M.J., Diaz, E., Fartoux, L., The Lille model: A new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids (2007) Hepatology, 45, pp. 1348-1354
Consensus conference: Indications for Liver Transplantation, January 19 and 20, 2005, Lyon-Palais Des Congrès: text of recommendations (long version), Liver Transpl
Marot, A., Dubois, M., Trépo, E., Moreno, C., Deltenre, P., Liver transplantation for alcoholic hepatitis: A systematic review with meta-analysis (2018) Plos One, 13
Lee, B.P., Mehta, N., Platt, L., Gurakar, A., Rice, J.P., Lucey, M.R., Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis (2018) Gastroenterology, 155, pp. 422-430. , e421
Alexandre Louvet, J.L., Christophe, M., Claire, V., Romain, M., Early liver transplantation for severe alcoholic hepatitis not reponding to medical treatment: Results of the French-Belgian prospective study quicktrans Hepatology, 2020 (72), pp. 4A-5A
Donckier, V., Lucidi, V., Gustot, T., Moreno, C., Ethical considerations regarding early liver transplantation in patients with severe alcoholic hepatitis not responding to medical therapy (2014) J. Hepatol., 60, pp. 866-871
Marot, A., Moreno, C., Deltenre, P., Liver transplant for alcoholic hepatitis: A current clinical overview (2020) Expert Rev. Gastroenterol. Hepatol., 14, pp. 591-600
Degroote, H., Callebout, E., Iesari, S., Dekervel, J., Schreiber, J., Pirenne, J., Extended criteria for liver transplantation in hepatocellular carcinoma. A retrospective, multicentric validation study in Belgium (2020) Surg. Oncol., 33, pp. 231-238
Adler, M., de Pauw, F., Vereerstraeten, P., Fancello, A., Lerut, J., Starkel, P., Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the Eurotransplant allocation system (2008) Liver Transpl, 14, pp. 526-533
Mazzaferro, V., Llovet, J.M., Miceli, R., Bhoori, S., Schiavo, M., Mariani, L., Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: A retrospective, exploratory analysis (2009) Lancet Oncol, 10, pp. 35-43
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis (1996) N. Engl. J. Med., 334, pp. 693-699
Amado, V., Rodríguez-Perálvarez, M., Ferrín, G., de La Mata, M., Selecting patients with hepatocellular carcinoma for liver transplantation: Incorporating tumor biology criteria (2019) J. Hepatocell. Carcinoma, 6, pp. 1-10
Kornberg, A., Witt, U., Schernhammer, M., Kornberg, J., Ceyhan, G.O., Mueller, K., Combining (18)F-FDG positron emission tomography with Up-to-seven criteria for selecting suitable liver transplant patients with advanced hepatocellular carcinoma, Sci (2017) Rep, 7, p. 14176
Detry, O., Govaerts, L., Deroover, A., Vandermeulen, M., Meurisse, N., Malenga, S., Prognostic value of (18)F-FDG PET/ CT in liver transplantation for hepatocarcinoma (2015) World J. Gastroenterol., 21, pp. 3049-3054
Kornberg, A., Freesmeyer, M., Bärthel, E., Jandt, K., Katenkamp, K., Steenbeck, J., 18F-FDG-uptake of hepatocellular carcinoma on PET predicts microvascular tumor invasion in liver transplant patients (2009) Am. J. Transplant., 9, pp. 592-600
Cronin, K.A., Lake, A.J., Scott, S., Sherman, R.L., Noone, A.M., Howlader, N., Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics (2018) Cancer, 124, pp. 2785-2800
Siegel, R.L., Miller, K.D., Jemal, A., Colorectal Cancer Mortality Rates in Adults Aged 20 to 54 Years in the United States, 1970-2014 (2017) Jama, 318, pp. 572-574
Steele, G., Jr., Ravikumar, T.S., Resection of hepatic metastases from colorectal cancer. Biologic perspective (1989) Ann. Surg., 210, pp. 127-138
Blumgart, L.H., Allison, D.J., Resection and embolization in the management of secondary hepatic tumors (1982) World J. Surg., 6, pp. 32-45
Adam, R., Delvart, V., Pascal, G., Valeanu, A., Castaing, D., Azoulay, D., Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: A model to predict long-term survival (2004) Ann.Surg., 240, pp. 644-657. , discussion 657-648
Khatri, V.P., Petrelli, N.J., Belghiti, J., Extending the frontiers of surgical therapy for hepatic colorectal metastases: Is there a limit? (2005) J. Clin. Oncol., 23, pp. 8490-8499
(1991) Hepatic Transplantation for Primary and Metastatic Cancers of the Liver, Surgery, 110, p. 726
Mühlbacher, F., Huk, I., Steininger, R., Gnant, M., Götzinger, P., Wamser, P., Is orthotopic liver transplantation a feasible treatment for secondary cancer of the liver? (1991) Transplant Proc, 23, pp. 1567-1568
Wasan, H.S., Gibbs, P., Sharma, N.K., Taieb, J., Heinemann, V., Ricke, J., First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): A combined analysis of three multicentre, randomised, phase 3 trials (2017) Lancet Oncol, 18, pp. 1159-1171
Hoti, E., Adam, R., Liver transplantation for primary and metastatic liver cancers (2008) Transpl. Int., 21, pp. 1107-1117
Dueland, S., Guren, T.K., Hagness, M., Glimelius, B., Line, P.D., Pfeiffer, P., Chemotherapy or liver transplantation for nonresectable liver metastases from colorectal cancer (2015) Ann. Surg, 261, pp. 956-960
Dueland, S., Foss, A., Solheim, J.M., Hagness, M., Line, P.D., Survival following liver transplantation for liver-only colorectal metastases compared with hepatocellular carcinoma (2018) Br. J. Surg., 105, pp. 736-742
Dueland, S., Grut, H., Syversveen, T., Hagness, M., Line, P.D., Selection criteria related to long-term survival following liver transplantation for colorectal liver metastasis (2020) Am. J. Transplant., 20, pp. 530-537
Dueland, S., Syversveen, T., Solheim, J.M., Solberg, S., Grut, H., Bjørnbeth, B.A., Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases (2020) Ann. Surg., 271, pp. 212-218
Nadalin, S., Königsrainer, A., Capobianco, I., Settmacher, U., Rauchfuss, F., Auxiliary living donor liver transplantation combined with two-stage hepatectomy for unresectable colorectal liver metastases (2019) Curr. Opin. Organ. Transplant., 24, pp. 651-658
Shah, A.P., Cameron, A., Singh, P., Frank, A.M., Fenkel, J.M., Successful treatment of donor-derived hepatitis C viral infection in three transplant recipients from a donor at increased risk for bloodborne pathogens (2017) Transpl. Infect. Dis., 19
Line, P.D., Hagness, M., Berstad, A.E., Foss, A., Dueland, S., A Novel Concept for Partial Liver Transplantation in Nonresectable Colorectal Liver Metastases: The RAPID Concept (2015) Ann. Surg., 262, pp. e5-e9
Königsrainer, A., Templin, S., Capobianco, I., Königsrainer, I., Bitzer, M., Zender, L., Paradigm Shift in the Management of Irresectable Colorectal Liver Metastases: Living Donor Auxiliary Partial Orthotopic Liver Transplantation in Combination With Two-stage Hepatectomy (LD-RAPID) (2019) Ann. Surg., 270, pp. 327-332
Rauchfuss, F., Nadalin, S., Königsrainer, A., Settmacher, U., Living donor liver transplantation with two-stage hepatectomy for patients with isolated, irresectable colorectal liver-the LIVER-T(W)O-HEAL study (2019) World J. Surg. Oncol., 17
Coubeau, L., Iesari, S., Ciccarelli, O., Bonaccorsi-Riani, E., Dahlqvist, G., Reding, R., Two-Stage Recipient Hepatectomy and Left Liver Transplantation to Minimize Risks in Adult-to-Adult Living Donor Liver Transplantation: New Concepts (2020) Liver Transpl, 26, pp. 450-455
Gurevich, M., Guy-Viterbo, V., Janssen, M., Stephenne, X., Smets, F., Sokal, E., Living Donor Liver Transplantation in Children: Surgical and Immunological Results in 250 Recipients at Université Catholique de Louvain (2015) Ann. Surg., 262, pp. 1141-1149
Grut, H., Solberg, S., Seierstad, T., Revheim, M.E., Egge, T.S., Larsen, S.G., Growth rates of pulmonary metastases after liver transplantation for unresectable colorectal liver metastases (2018) Br. J. Surg., 105, pp. 295-301
Wang, X.W., Zhang, Y.J., Targeting mTOR network in colorectal cancer therapy (2014) World J. Gastroenterol., 20, pp. 4178-4188
Jørgensen, K.K., Lindström, L., Cvancarova, M., Castedal, M., Friman, S., Schrumpf, E., Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: A Nordic multicenter study, Scand (2012) J. Gastroenterol, 47, pp. 1021-1029
Merchea, A., Shahjehan, F., Croome, K.P., Cochuyt, J.J., Li, Z., Colibaseanu, D.T., Colorectal Cancer Characteristics and Outcomes after Solid Organ Transplantation (2019) J. Oncol., 2019
Line, P.D., Dueland, S., Liver transplantation for secondary liver tumours: The difficult balance between survival and recurrence (2020) J. Hepatol., 73, pp. 1557-1562
Crismale, J.F., Ahmad, J., Expanding the donor pool: Hepatitis C, hepatitis B and human immunodeficiency virus-positive donors in liver transplantation (2019) World J. Gastroenterol., 25, pp. 6799-6812
Fabrizi, F., Martin, P., Dixit, V., Bunnapradist, S., Dulai, G., Hepatitis C virus antibody status and survival after renal transplantation: Meta-analysis of observational studies (2005) Am. J. Transplant., 5, pp. 1452-1461
Mathurin, P., Mouquet, C., Poynard, T., Sylla, C., Benalia, H., Fretz, C., Impact of hepatitis B and C virus on kidney transplantation outcome (1999) Hepatology, 29, pp. 257-263
Sise, M.E., Chute, D.F., Gustafson, J.L., Wojciechowski, D., Elias, N., Chung, R.T., Transplantation of hepatitis C virus infected kidneys into hepatitis C virus uninfected recipients (2018) Hemodial. Int., 22, pp. S71-s80
Northup, P.G., Argo, C.K., Nguyen, D.T., McBride, M.A., Kumer, S.C., Schmitt, T.M., Liver allografts from hepatitis C positive donors can offer good outcomes in hepatitis C positive recipients: A US National Transplant Registry analysis (2010) Transpl. Int., 23, pp. 1038-1044
Stepanova, M., Sayiner, M., de Avila, L., Younoszai, Z., Racila, A., Younossi, Z.M., Long-term outcomes of liver transplantation in patients with hepatitis C infection are not affected by HCV positivity of a donor (2016) BMC Gastroenterol, 16
Cotter, T.G., Aronsohn, A., Reddy, K.G., Charlton, M., Liver Transplantation of HCV-Viremic Donors into HCV-Negative Recipients in the USA: Increasing Frequency with Profound Geographic Variation (2020) Transplantation
Cotter, T.G., Paul, S., Sandikçi, B., Couri, T., Bodzin, A.S., Little, E.C., Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Following Liver Transplant of HCV-Viremic Donors (2019) Hepatology, 69, pp. 2381-2395
Thuluvath, P.J., Bruno, D.A., Alukal, J., Satapathy, S.K., Thuluvath, A.J., Zhang, T., Use of HCV-Positive Livers in HCV-Negative Recipients (2020) Am. J. Gastroenterol., 115, pp. 1045-1054
Polanco, N.P., Goldberg, D., Transplanting Livers From “HCV-Positive” Donors To HCV-Negative Recipients: Increased Experience But Many Unanswered Questions (2020) Am. J. Gastroenterol., 115, pp. 1022-1023
Luckett, K., Kaiser, T.E., Bari, K., Safdar, K., Schoech, M.R., Apewokin, S., Use of Hepatitis C Virus Antibody-Positive Donor Livers in Hepatitis C Nonviremic Liver Transplant Recipients (2019) J. Am. Coll. Surg, 228, pp. 560-567
Bari, K., Luckett, K., Kaiser, T., Diwan, T., Cuffy, M., Schoech, M.R., Hepatitis C transmission from seropositive, nonviremic donors to non-hepatitis C liver transplant recipients (2018) Hepatology, 67, pp. 1673-1682
de Vera, M.E., Volk, M.L., Ncube, Z., Blais, S., Robinson, M., Allen, N., Transplantation of hepatitis C virus (HCV) antibody positive, nucleic acid test negative donor kidneys to HCV negative patients frequently results in seroconversion but not HCV viremia (2018) Am. J. Transplant., 18, pp. 2451-2456
Patel, S.R., Madan, S., Saeed, O., Sims, D.B., Shin, J.J., Nucci, C., Cardiac transplantation from non-viremic hepatitis C donors (2018) J. Heart Lung Transplant, 37, pp. 1254-1260
Levitsky, J., Formica, R.N., Bloom, R.D., Charlton, M., Curry, M., Friedewald, J., The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation (2017) Am. J. Transplant, 17, pp. 2790-2802
Seem, D.L., Lee, I., Umscheid, C.A., Kuehnert, M.J., PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation (2013) Public Health Rep, 128, pp. 247-343
Agbim, U., Cseprekal, O., Yazawa, M., Talwar, M., Balaraman, V., Bhalla, A., Factors associated with hepatitis C antibody seroconversion after transplantation of kidneys from hepatitis C infected donors to hepatitis C naïve recipients (2020) Ren. Fail, 42, pp. 767-775
Post-transplant survey to assess patient experiences with donor-derived HCV infection, Transpl (2020) Infect. Dis.
Campos-Varela, I., Agudelo, E.Z., Sarkar, M., Roberts, J.P., Terrault, N.A., Use of a hepatitis C virus (HCV) RNA-positive donor in a treated HCV RNA-negative liver transplant recipient (2018) Transpl. Infect. Dis., 20
Kwong, A.J., Wall, A., Melcher, M., Wang, U., Ahmed, A., Subramanian, A., Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors (2019) Am. J. Transplant, 19, pp. 1380-1387
Bethea, E., Arvind, A., Gustafson, J., Andersson, K., Pratt, D., Bhan, I., Immediate administration of antiviral therapy after transplantation of hepatitis C-infected livers into uninfected recipients: Implications for therapeutic planning (2020) Am. J. Transplant., 20, pp. 1619-1628
Bohorquez, H., Bugeaud, E., Bzowej, N., Scheuermann, J., Hand, J., Bruce, D., Liver Transplantation Using Hepatitis C Virus-Viremic Donors Into Hepatitis C Virus-Aviremic Recipients as Standard of Care (2020) Liver Transpl
Said, A., Weiss, M., Varhelyi, A., Farago, R., Ballweg, C., Rice, J., Utilization of hepatitis C viremic donors for liver transplant recipients without hepatitis C. A veterans transplant center report (2020) Transpl. Infect. Dis.
Crismale, J.F., Khalid, M., Bhansali, A., de Boccardo, G., Khaim, R., Florman, S.S., Liver, simultaneous liver-kidney, and kidney transplantation from hepatitis C-positive donors in hepatitis C-negative recipients: A single-center study Clin. Transplant., 2020 (34)
(2020) Hepatitis C Virus Nat-Positive Solid Organ Allografts Transplanted into Hepatitis C Virus-Negative Recipients: A Real-World Experience, Hepatology, 72, pp. 32-41
Franco, A., Moreso, F., Merino, E., Sancho, A., Kanter, J., Gimeno, A., Renal transplantation from seropositive hepatitis C virus donors to seronegative recipients in Spain: A prospective study (2019) Transpl. Int., 32, pp. 710-716
Durand, C.M., Bowring, M.G., Brown, D.M., Chattergoon, M.A., Massaccesi, G., Bair, N., Direct-Acting Antiviral Prophylaxis in Kidney Transplantation From Hepatitis C Virus-Infected Donors to Noninfected Recipients: An Open-Label Nonrandomized Trial (2018) Ann. Intern. Med, 168, pp. 533-540
Reese, P.P., Abt, P.L., Blumberg, E.A., van Deerlin, V.M., Bloom, R.D., Potluri, V.S., Twelve-Month Outcomes After Transplant of Hepatitis C-Infected Kidneys Into Uninfected Recipients: A Single-Group Trial (2018) Ann. Intern. Med., 169, pp. 273-281
Wettersten, N., Tran, H., Mekeel, K., Pretorius, V., Adler, E., Aslam, S., Successful heart-kidney transplantation from a Hepatitis C viremic donor to negative recipient: One year of follow-up (2019) Transpl. Infect. Dis., 21
McLean, R.C., Reese, P.P., Acker, M., Atluri, P., Bermudez, C., Goldberg, L.R., Transplanting hepatitis C virus-infected hearts into uninfected recipients: A single-arm trial (2019) Am. J. Transplant., 19, pp. 2533-2542
Bethea, E.D., Gaj, K., Gustafson, J.L., Axtell, A., Lebeis, T., Schoenike, M., Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: An open-label study, Lancet Gastroenterol (2019) Hepatol, 4, pp. 771-780
Schlendorf, K.H., Zalawadiya, S., Shah, A.S., Wigger, M., Chung, C.Y., Smith, S., Early outcomes using hepatitis C-positive donors for cardiac transplantation in the era of effective direct-acting antiviral therapies (2018) J. Heart Lung Transplant, 37, pp. 763-769
Zhu, Y., Shudo, Y., Lee, R., Woo, Y.J., Heart Transplant Using Hepatitis C-Seropositive and Viremic Organs in Seronegative Recipients Ann. Transplant., 2020 (25)
Smith, D.E., Chen, S., Fargnoli, A., Lewis, T., Galloway, A.C., Kon, Z.N., Impact of Early Initiation of Direct-Acting Antiviral Therapy in Thoracic Organ Transplantation From Hepatitis C Virus Positive Donors (2020) Semin. Thorac. Cardiovasc. Surg.
Cypel, M., Feld, J.J., Galasso, M., Pinto Ribeiro, R.V., Marks, N., Kuczynski, M., Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: An open-label, single-centre, pilot trial (2020) Lancet Respir. Med., 8, pp. 192-201
Mansour, M., Hill, L., Kerr, J., Safety and effectiveness of direct acting antivirals for treatment of hepatitis C virus in patients with solid organ transplantation (2018) Transpl. Infect. Dis., 20
Cohen, E., Liapakis, A., Pharmacokinetics and important drug-drug interactions to remember when treating advanced chronic kidney disease patients with hepatitis C direct acting anti-viral therapy (2019) Semin. Dial., 32, pp. 141-151
Liu, J., Ma, B., Cao, W., Li, M., Bramer, W.M., Peppelenbosch, M.P., Direct-acting antiviral agents for liver transplant recipients with recurrent genotype 1 hepatitis C virus infection: Systematic review and meta-analysis (2019) Transpl. Infect. Dis., 21
Litzroth, A., Suin, V., Wyndham-Thomas, C., Quoilin, S., Muyldermans, G., Vanwolleghem, T., Low hepatitis C prevalence in Belgium: Implications for treatment reimbursement and scale up (2019) BMC Public Health, 19
Matheï, C., Bourgeois, S., Blach, S., Brixko, C., Mulkay, J.P., Razavi, H., Mitigating the burden of hepatitis C virus among people who inject drugs in Belgium, Acta Gastroenterol (2016) Belg, 79, pp. 227-232
(2020) Liver and Kidney Recipient Selection of Hepatitis C Virus Viremic Donors: Meeting Consensus Report from the 2019 Controversies in Transplantation, Transplantation, 104, pp. 476-481
Jochmans, I., van Rosmalen, M., Pirenne, J., Samuel, U., Adult Liver Allocation in Eurotransplant (2017) Transplantation, 101, pp. 1542-1550
Lee, B.P., Chen, P.H., Haugen, C., Hernaez, R., Gurakar, A., Philosophe, B., Three-year Results of a Pilot Program in Early Liver Transplantation for Severe Alcoholic Hepatitis (2017) Ann. Surg, 265, pp. 20-29
Jochmans, I., Akhtar, M.Z., Nasralla, D., Kocabayoglu, P., Boffa, C., Kaisar, M., Past, Present, and Future of Dynamic Kidney and Liver Preservation and Resuscitation (2016) Am. J. Transplant, 16, pp. 2545-2555
Watson, C.J.E., Jochmans, I., From “Gut Feeling” to Objectivity: Machine Preservation of the Liver as a Tool to Assess Organ Viability (2018) Curr. Transplant. Rep., 5, pp. 72-81
Braat, A.E., Blok, J.J., Putter, H., Adam, R., Burroughs, A.K., Rahmel, A.O., The Eurotransplant donor risk index in liver transplantation: ET-DRI (2012) Am. J. Transplant., 12, pp. 2789-2796
Characteristics associated with liver graft failure: The concept of a donor risk index, Am (2006) J. Transplant., 6, pp. 783-790
Watson, C.J., Johnson, R.J., Birch, R., Collett, D., Bradley, J.A., A simplified donor risk index for predicting outcome after deceased donor kidney transplantation (2012) Transplantation, 93, pp. 314-318
Maione, F., Gilbo, N., Lazzaro, S., Friend, P., Camussi, G., Romagnoli, R., Porcine Isolated Liver Perfusion for the Study of Ischemia Reperfusion Injury: A Systematic Review (2018) Transplantation, 102, pp. 1039-1049
Nasralla, D., Coussios, C.C., Mergental, H., Akhtar, M.Z., Butler, A.J., Ceresa, C.D.L., A randomized trial of normothermic preservation in liver transplantation (2018) Nature, 557, pp. 50-56
Ceresa, C., Nasralla, D., Watson, C., Butler, A., Crick, K., Imber, C., The effect of normothermic machine perfusion after cold storage in liver transplantation: A multicentre prospective clinical trial (2018) Transplantation, 102, pp. 27-27
Mergental, H., Perera, M.T., Laing, R.W., Muiesan, P., Isaac, J.R., Smith, A., Transplantation of Declined Liver Allografts Following Normothermic Ex-Situ Evaluation (2016) Am. J. Transplant, 16, pp. 3235-3245
Perera, T., Mergental, H., Stephenson, B., Roll, G.R., Cilliers, H., Liang, R., First human liver transplantation using a marginal allograft resuscitated by normothermic machine perfusion (2016) Liver Transpl, 22, pp. 120-124
Watson, C.J.E., Kosmoliaptsis, V., Randle, L.V., Gimson, A.E., Brais, R., Klinck, J.R., Normothermic Perfusion in the Assessment and Preservation of Declined Livers Before Transplantation: Hyperoxia and Vasoplegia-Important Lessons From the First 12 Cases (2017) Transplantation, 101, pp. 1084-1098
Watson, C.J., Kosmoliaptsis, V., Randle, L.V., Russell, N.K., Griffiths, W.J., Davies, S., Preimplant Normothermic Liver Perfusion of a Suboptimal Liver Donated After Circulatory Death (2016) Am. J. Transplan, 16, pp. 353-357
Watson, C.J., Randle, L.V., Kosmoliaptsis, V., Gibbs, P., Allison, M., Butler, A.J., 26-hour Storage of a Declined Liver Before Successful Transplantation Using Ex Vivo Normothermic Perfusion (2017) Ann. Surg., 265, pp. e1-e2
Watson, C.J.E., Kosmoliaptsis, V., Pley, C., Randle, L., Fear, C., Crick, K., Observations on the ex situ perfusion of livers for transplantation (2018) Am. J. Transplant, 18, pp. 2005-2020
Mergental, H., Laing, R.W., Kirkham, A.J., Perera, T.P.R., Boteon, Y., Attard, J., Transplantation after Viability Testing of Discarded Livers with Normothermic Machine Perfusion (NMP): The Vittal (VIability Testing and Transplantation of Marginal Livers) Trial 90-Day Outcomes (2018) Hepatology, 68, pp. 1A-1A
de Vries, Y., Matton, A.P.M., Nijsten, M.W.N., Werner, M.J.M., van Den Berg, A.P., de Boer, M.T., Pretransplant sequential hypo- (2019) Am. J. Transplant., 19, pp. 1202-1211
Mergental, H., Laing, R.W., Kirkham, A.J., Perera, M., Boteon, Y.L., Attard, J., Transplantation of discarded livers following viability testing with normothermic machine perfusion, Nat Commun, 2020, p. 11
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.
